Dipyridamole for COVID-19

You can also use the and keys

~~Deletions are marked like this~~	Additions are marked like this
Dipyridamole, a vasodilator and antiplatelet drug, has been proposed as a possible COVID-19 therapeutic. See also COVID-19 therapeutics	Dipyridamole, a vasodilator and antiplatelet drug, has been proposed as a possible COVID-19 therapeutic. Mechanism of potential benefit See the research overview by Yogendra Kanthi, Jason S. Knight, et. al: "New (re)purpose for an old drug: purinergic modulation may extinguish the COVID-19 thromboinflammatory firestorm" Clinical trials A list of clinical trials of dipyridamole for COVID-19: Dipyridamole to Prevent Coronavirus Exacerbation of Respiratory Status (DICER) in COVID-19 (DICER). Intervention: Dipyridamole 100mg po 4 times a day Aggrenox To Treat Acute Covid-19 (ATTAC-19) Intervention: Dipyridamole ER 200mg/ Aspirin 25mg bid for 2 weeks. Trial of Open Label Dipyridamole- In Hospitalized Patients With COVID-19 (TOLD). Intervention: Dipyridamole 100mg 3 times a day for 7 days See also COVID-19 therapeutics

~~Deletions are marked like this~~

Additions are marked like this

Dipyridamole, a vasodilator and antiplatelet drug, has been proposed as a possible COVID-19 therapeutic.

A list of clinical trials of dipyridamole for COVID-19:

philipn / Dipyridamole for COVID-19 cac66ba4c053af0b5e1dae942fd8f8d5037515b7